Shares of Moderna Inc. MRNA, -3.20% slid 3.20% to $236.85 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP, -0.60% falling 0.60% to 15,886.54 and Dow Jones Industrial Average DJIA, -0.31% falling 0.31% to 36,319.98. Moderna Inc. closed $260.64 below its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. ABBV, -0.39% fell 0.39% to $115.61, Amgen Inc. AMGN, +0.16% rose 0.16% to $211.71, and AstraZeneca PLC ADR AZN, -0.46% fell 0.46% to $62.70. Trading volume (10.9 M) remained 2.3 million below its 50-day average volume of 13.2 M.